Open AccessLONG-TERM OUTCOMES IN HEART TRANSPLANT RECIPIENTS WHO RECEIVED GANCICLOVIR PROPHYLAXIS: IMPACT OF CMV AND CMV SEROSTATUS ON REJECTION, ALLOGRAFT VASCULOPATHY, AND SURVIVAL.
Author(s) -
Robin K. Avery,
Sherif B. Mossad,
James B. Young,
Marlene Goormastic,
Randall C. Starling,
Katherine J. Hoercher,
Robert E. Hobbs,
D. Pelegrin,
Steven D. Mawhorter,
Patrick M. McCarthy
Publication year - 2000
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200004271-00486
Subject(s) - serostatus , ganciclovir , medicine , cytomegalovirus , term (time) , starling , theology , human cytomegalovirus , immunology , human immunodeficiency virus (hiv) , philosophy , viral load , virus , herpesviridae , viral disease , physics , quantum mechanics